Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Moros

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Archives of Neurology|December 1, 1989
Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patientsT S Elizan, M D Yahr, D A Moros, et al.
Archives of Neurology|December 1, 1989
Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novo patientsT S Elizan, M D Yahr, D A Moros, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Archives of Neurology|December 1, 1989
Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patientsT S Elizan, M D Yahr, D A Moros, et al.
Archives of Neurology|December 1, 1989
Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novo patientsT S Elizan, M D Yahr, D A Moros, et al.
Pageof 2